These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 35008530)

  • 81. STMN2 mediates nuclear translocation of Smad2/3 and enhances TGFβ signaling by destabilizing microtubules to promote epithelial-mesenchymal transition in hepatocellular carcinoma.
    Zhong FJ; Sun B; Cao MM; Xu C; Li YM; Yang LY
    Cancer Lett; 2021 May; 506():128-141. PubMed ID: 33705863
    [TBL] [Abstract][Full Text] [Related]  

  • 82. The role of XBP1s in the metastasis and prognosis of hepatocellular carcinoma.
    Wu S; Du R; Gao C; Kang J; Wen J; Sun T
    Biochem Biophys Res Commun; 2018 Jun; 500(3):530-537. PubMed ID: 29627568
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Regorafenib inhibits migration, invasion, and vasculogenic mimicry of hepatocellular carcinoma via targeting ID1-mediated EMT.
    Zhang N; Zhang S; Wu W; Lu W; Jiang M; Zheng N; Huang J; Wang L; Liu H; Zheng M; Wang J
    Mol Carcinog; 2021 Feb; 60(2):151-163. PubMed ID: 33428809
    [TBL] [Abstract][Full Text] [Related]  

  • 84. MicroRNA-630 suppresses tumor metastasis through the TGF-β- miR-630-Slug signaling pathway and correlates inversely with poor prognosis in hepatocellular carcinoma.
    Chen WX; Zhang ZG; Ding ZY; Liang HF; Song J; Tan XL; Wu JJ; Li GZ; Zeng Z; Zhang BX; Chen XP
    Oncotarget; 2016 Apr; 7(16):22674-86. PubMed ID: 26993767
    [TBL] [Abstract][Full Text] [Related]  

  • 85. NTS/NTR1 co-expression enhances epithelial-to-mesenchymal transition and promotes tumor metastasis by activating the Wnt/β-catenin signaling pathway in hepatocellular carcinoma.
    Ye Y; Long X; Zhang L; Chen J; Liu P; Li H; Wei F; Yu W; Ren X; Yu J
    Oncotarget; 2016 Oct; 7(43):70303-70322. PubMed ID: 27611941
    [TBL] [Abstract][Full Text] [Related]  

  • 86. BRD4 promotes tumor growth and epithelial-mesenchymal transition in hepatocellular carcinoma.
    Zhang P; Dong Z; Cai J; Zhang C; Shen Z; Ke A; Gao D; Fan J; Shi G
    Int J Immunopathol Pharmacol; 2015 Mar; 28(1):36-44. PubMed ID: 25816404
    [TBL] [Abstract][Full Text] [Related]  

  • 87. ZnAs@SiO
    Huang Y; Zhou B; Luo H; Mao J; Huang Y; Zhang K; Mei C; Yan Y; Jin H; Gao J; Su Z; Pang P; Li D; Shan H
    Theranostics; 2019; 9(15):4391-4408. PubMed ID: 31285768
    [No Abstract]   [Full Text] [Related]  

  • 88. Metadherin promotes hepatocellular carcinoma metastasis through induction of epithelial-mesenchymal transition.
    Zhu K; Dai Z; Pan Q; Wang Z; Yang GH; Yu L; Ding ZB; Shi GM; Ke AW; Yang XR; Tao ZH; Zhao YM; Qin Y; Zeng HY; Tang ZY; Fan J; Zhou J
    Clin Cancer Res; 2011 Dec; 17(23):7294-302. PubMed ID: 21976539
    [TBL] [Abstract][Full Text] [Related]  

  • 89. NCSTN promotes hepatocellular carcinoma cell growth and metastasis via β-catenin activation in a Notch1/AKT dependent manner.
    Li H; Lan T; Xu L; Liu H; Wang J; Li J; Chen X; Huang J; Li X; Yuan K; Zeng Y; Wu H
    J Exp Clin Cancer Res; 2020 Jul; 39(1):128. PubMed ID: 32631394
    [TBL] [Abstract][Full Text] [Related]  

  • 90. miR-203 inhibits augmented proliferation and metastasis of hepatocellular carcinoma residual in the promoted regenerating liver.
    Zheng XB; Chen XB; Xu LL; Zhang M; Feng L; Yi PS; Tang JW; Xu MQ
    Cancer Sci; 2017 Mar; 108(3):338-346. PubMed ID: 28100026
    [TBL] [Abstract][Full Text] [Related]  

  • 91. IQGAP1 promotes pancreatic cancer progression and epithelial-mesenchymal transition (EMT) through Wnt/β-catenin signaling.
    Hu W; Wang Z; Zhang S; Lu X; Wu J; Yu K; Ji A; Lu W; Wang Z; Wu J; Jiang C
    Sci Rep; 2019 May; 9(1):7539. PubMed ID: 31101875
    [TBL] [Abstract][Full Text] [Related]  

  • 92. FAM188B promotes the growth, metastasis, and invasion of hepatocellular carcinoma by targeting the hnRNPA1/PKM2 axis.
    Mu M; Lu Y; Tu K; Tu L; Guo C; Li Z; Zhang X; Chen Y; Liu X; Xu Q; Huang D; Li X
    Biochim Biophys Acta Mol Cell Res; 2024 Oct; 1871(7):119773. PubMed ID: 38844182
    [TBL] [Abstract][Full Text] [Related]  

  • 93. MicroRNA-1296 inhibits metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by targeting SRPK1-mediated PI3K/AKT pathway.
    Xu Q; Liu X; Liu Z; Zhou Z; Wang Y; Tu J; Li L; Bao H; Yang L; Tu K
    Mol Cancer; 2017 Jun; 16(1):103. PubMed ID: 28606154
    [TBL] [Abstract][Full Text] [Related]  

  • 94. PBK overexpression promotes metastasis of hepatocellular carcinoma via activating ETV4-uPAR signaling pathway.
    Yang QX; Zhong S; He L; Jia XJ; Tang H; Cheng ST; Ren JH; Yu HB; Zhou L; Zhou HZ; Ren F; Hu ZW; Gong R; Huang AL; Chen J
    Cancer Lett; 2019 Jun; 452():90-102. PubMed ID: 30914208
    [TBL] [Abstract][Full Text] [Related]  

  • 95. HIF-2α activated lncRNA NEAT1 promotes hepatocellular carcinoma cell invasion and metastasis by affecting the epithelial-mesenchymal transition.
    Zheng X; Zhang Y; Liu Y; Fang L; Li L; Sun J; Pan Z; Xin W; Huang P
    J Cell Biochem; 2018 Apr; 119(4):3247-3256. PubMed ID: 29091312
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Macrophage-secreted IL-8 induces epithelial-mesenchymal transition in hepatocellular carcinoma cells by activating the JAK2/STAT3/Snail pathway.
    Fu XT; Dai Z; Song K; Zhang ZJ; Zhou ZJ; Zhou SL; Zhao YM; Xiao YS; Sun QM; Ding ZB; Fan J
    Int J Oncol; 2015 Feb; 46(2):587-96. PubMed ID: 25405790
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Decreased TIP30 promotes Snail-mediated epithelial-mesenchymal transition and tumor-initiating properties in hepatocellular carcinoma.
    Zhu M; Yin F; Fan X; Jing W; Chen R; Liu L; Zhang L; Liu Y; Liang Y; Bu F; Tong X; Zheng H; Zhao J; Guo Y
    Oncogene; 2015 Mar; 34(11):1420-31. PubMed ID: 24681951
    [TBL] [Abstract][Full Text] [Related]  

  • 98. The lincRNA-ROR/miR-145 axis promotes invasion and metastasis in hepatocellular carcinoma via induction of epithelial-mesenchymal transition by targeting ZEB2.
    Li C; Lu L; Feng B; Zhang K; Han S; Hou D; Chen L; Chu X; Wang R
    Sci Rep; 2017 Jul; 7(1):4637. PubMed ID: 28680141
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Super-enhancer-driven AJUBA is activated by TCF4 and involved in epithelial-mesenchymal transition in the progression of Hepatocellular Carcinoma.
    Zhang C; Wei S; Sun WP; Teng K; Dai MM; Wang FW; Chen JW; Ling H; Ma XD; Feng ZH; Duan JL; Cai MY; Xie D
    Theranostics; 2020; 10(20):9066-9082. PubMed ID: 32802179
    [No Abstract]   [Full Text] [Related]  

  • 100. MicroRNA‑3653 inhibits the growth and metastasis of hepatocellular carcinoma by inhibiting ITGB1.
    Zhang L; Zhang T; Deng Z; Sun L
    Oncol Rep; 2019 Mar; 41(3):1669-1677. PubMed ID: 30664185
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.